期刊文献+

新型快速病理诊断技术在超声引导下甲状腺癌穿刺检查中应用的临床价值探讨 被引量:7

Clinical value of application of new rapid pathological diagnosis technology in ultrasound-guided puncture in thyroid cancer
下载PDF
导出
摘要 目的 探讨新型快速病理诊断技术在甲状腺癌穿刺检查中应用的临床价值。方法 选择本院2017年7月至2018年6月期间术前倾向于甲状腺癌且经术后病理证实的甲状腺穿刺患者12例,其中8例采用US-FNA检查,4例采用US-CNB检查,在甲状腺穿刺操作过程中采用新型快速病理诊断技术进行实时细胞学初诊,并依据快速病理诊断结果实时调整穿刺操作方案,分析新型快速病理诊断技术在甲状腺癌穿刺检查中的临床价值。结果 新型快速病理诊断技术开展所需空间小,无污染,诊断耗时2~3min,不影响正常穿刺操作。8例US-FNA中的2例(25.0%)与4例US-CNB中的1例(25.0%)在本技术协助下达到穿刺操作对肿瘤成分质与量的要求。结论 确诊甲状腺癌的US-FNA检查或US-CNB检查,均会因多种因素的干扰而影响到诊断的质量。新型快速病理诊断技术在可甲状腺穿刺过程中提供实时病理诊断,以此确保穿刺组织中肿瘤成分的质与量,保证甲状腺穿刺的首次成功率,且本技术开展成本低,适宜在各级医院推广施行。 Objective To explore the clinical value of applying new rapid pathological diagnosis technology in ultrasound-guided puncture in thyroid cancer.Methods Twelve patients taking thyroid puncture who preoperatively tended to have thyroid cancer and were confirmed by postoperative pathology were selected.Among which,8 cases were examined with US-FNA,and 4 with US-CNB.The new rapid pathological diagnosis technique was used during thyroid puncture operation.Real-time cytology was first diagnosed and the puncture operation plan was adjusted in real time according to the results of rapid pathological diagnosis.The clinical value of new rapid pathological diagnosis technique in thyroid cancer puncture was analyzed.Results The new rapid pathological diagnosis technology required a small space and had no pollution.The diagnosis took about 2 to 3 minutes and did not affect the normal puncture biopsy operation.2 cases(25.0%)of the 8 taking US-FNAs and 1 case(25.0%)of the 4 taking US-CNBs with the assistance of this technology confirmed the requirement of biopsy quality and quantity.Conclusion Because of various factors,the quality and quantity of biopsy tissue are often not guaranteed in the US-FNA or US-CNB tests.The new rapid pathological diagnosis technology can provide real-time pathological diagnosis during thyroid puncture and improve the quality and quantity of puncture tissue,and ensure the first success rate of thyroid puncture;and the cost of this technology is low;so it is suitable for implementation in hospitals at all levels.
作者 王磊 丁永玲 周洁 刘爽 万晓洁 戚庭月 李念芬 封淏 Wang Lei;Ding Yongling;Zhou Jie;Liu Shuang;Wan Xiaojie;Qi Tingyue;Li Nianfen;Feng Hao(Department of Pathology,Hospital Affiliated to Yangzhou University,Yangzhou 225009,China;Department of Ultrasound,Hospital Affiliated to Yangzhou University,Yangzhou 225009,China)
出处 《国际医药卫生导报》 2019年第12期1904-1908,共5页 International Medicine and Health Guidance News
基金 扬州市科技局社会发展面上项目(YZ2017085).
关键词 新型快速病理诊断技术 甲状腺癌 US-FNA US-CNB 临床价值 New rapid pathological diagnosis technique Thyroid cancer US-FNA US-CNB Clinical value
  • 相关文献

参考文献9

二级参考文献119

  • 1董舒,常才.超声引导下甲状腺细针穿刺活检的研究与进展[J].中华医学超声杂志(电子版),2013,10(6):433-436. 被引量:29
  • 2赵光明,张雪鹏,马琳,李瑞伟,朱红成,张文杰.彩色多普勒引导下甲状腺结节粗针穿刺活检的诊断意义[J].实用癌症杂志,2004,19(4):420-421. 被引量:20
  • 3谢朝艳,杜心芳,顾世明.超声引导粗针活检技术在甲状腺肿块诊断中的价值[J].临床医学,2007,27(1):8-9. 被引量:23
  • 4Cooper DS,Doherty GM,Haugen BR,et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid,2009,19(11):1167-1214.
  • 5Creutzig H. High or low dose radioiodine ablation of thyroid remnants[J]. Eur J Nucl Med,1987,12(10):500-502.
  • 6Johansen K,Woodhouse NJY,Odugbesan O. Comparison of 1073 MBq and 3700 MBq iodine-131 in post-operative ablation of residual thyroid tissue in patients with differentiated thyroid cancer[J]. J Nucl Med,1991,32(2):252-254.
  • 7Bal CS,Padhy AK,Jana S,et al. Prospective randomized clinical comparison to evaluate the optimal dose of 131-I for remnant ablation in patients with differentiated thyroid carcinoma[J]. Cancer,1996,77(12):2574-2580.
  • 8Bal CS,Kumar A,Pant GS. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma:a randomized clinical comparison in 509 patients[J]. J Clin Endocr Metab,2004,89(4):1666-1673.
  • 9Bal C,Chandra P,Kumar A,et al. A randomized equivalence comparison to determine the optimum dose of iodine-131 for remnant ablation in differentiated thyroid cancer[J]. Nucl Med Commun,2012,33(10):1039-1047.
  • 10Caglar M,Bozkurt FM,Akca CK,et al. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer[J]. Nucl Med Commun,2012,33(2):268-274.

共引文献262

同被引文献50

引证文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部